www.hhs.gov U.S. Department of Health and Human Services

Pregnancy and Lactation Medication Information for the Healthcare Provider

Enroll
Step Status
Educational Content ✘
Posttest ✘
Evaluation ✘
Starts On: Tue, 6/21/22: 12:00 AM EDT
Ends On: Tue, 12/31/24: 12:00 AM EST
Type: Enduring Material
Credits: 1
Description: FDA implemented a revised pregnancy and lactation labeling system. The updated labeling system replaces the pregnancy letter categories – A, B, C, D and X – used to classify prescription drugs used during pregnancy with a description of risks within the real-world context of caring for pregnant people who may need medication. This presentation provides an overview of the current pregnancy and lactation labeling system, also known as the Pregnancy and Lactation Labeling Rule (PLLR), lessons learned, and feedback received from healthcare providers. Further, it will help learners examine how prescription drug labeling can be used to inform prescribing in pregnant and lactating individuals.
Objectives:
  • Discuss the history of pregnancy and lactation labeling.
  • Explain the current prescription drug labeling for pregnancy, lactation, and females and males of reproductive potential.
  • Describe the FDA review process for incorporating information in prescription labeling on drug use in pregnancy and lactation.
  • Identify the limitations of prescription drug labeling recommendations (i.e., lack of data, quality of limited data).
  • Examine how prescription drug labeling can be used to inform prescribing in pregnant and lactating individuals.
Additional Information: Review the Activity Announcement for additional details: Announcement Form

Additional Resources: SLIDES
ACCME Joint Accreditation
  • This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
  • This system is provided for Government-authorized use only.
  • Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
  • Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
  • By using this system, you understand and consent to the following:
    • The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
    • Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.